TORONTO — The Canadian Partnership Against Cancer is pleased to see that the federal budget released yesterday in Ottawa confirmed ongoing funding to the Canadian Partnership Against Cancer for $47.5 million annually. This is confirmation that the Government of Canada will continue to support the Partnership and our collaborative model on progressing the Canadian Strategy for Cancer Control.
“We are grateful to see this commitment in the federal budget,” said Partnership CEO Shelly Jamieson. “I look forward to working with our partners across the country to further our efforts for Canadians touched by cancer.”
For a decade, the Partnership has worked collaboratively with key stakeholders to reduce the number of diagnoses and deaths in our country and improve the quality of life for Canadians living with cancer. Our work covers the full spectrum of what is needed to control cancer, from monitoring cancer system performance to supporting improvements in cancer prevention, diagnosis, treatment, survivorship and end of life care.
The Partnership will build on the joint accomplishments of the cancer control community and further develop its areas of focus around the themes of quality, equity, seamless patient experience, maximizing data impact and sustainability of the system, as outlined in our 2017-2022 Strategic Plan.
For more information, please contact:
Director of Communications
Canadian Partnership Against Cancer
(416) 619-5741 Cell: (647) 242-1053
About the Canadian Partnership Against Cancer
The Canadian Partnership Against Cancer works with Canada’s cancer community to reduce the burden of cancer on Canadians. Grounded in and informed by the experiences of those affected by cancer, the organization works with partners to support multi-jurisdictional uptake of evidence that will help to optimize cancer control planning and drive improvements in quality of practice across Canada. Through sustained effort and a focus on the cancer continuum, the organization supports the work of the collective cancer community in achieving long-term population outcomes: reduced incidence of cancer, less likelihood of Canadians dying from cancer, and an enhanced quality of life of those affected by cancer.